Arcadia Biosciences, Inc. (RKDA) › Operating IncomeArcadia Biosciences, Inc. (RKDA) — Operating IncomeAnnual figures by period end, from SEC filings.2014-12-31: -$15.15M2015-12-31: -$15.56M2016-12-31: -$18.62M2017-12-31: -$14.31M2018-12-31: -$16.87M2019-12-31: -$19.38M2020-12-31: -$12.78M2021-12-31: -$35.53M2022-12-31: -$14.01M2023-12-31: -$6.10M2024-12-31: -$3.65M2025-12-31: -$2.50M-$2.50M2014-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$2.50M—2026-03-26From 2025-01-012024-12-31-$3.65M—2026-03-26From 2024-01-012023-12-31-$6.10M—2025-03-25From 2023-01-012022-12-31-$14.01M—2024-03-28From 2022-01-012021-12-31-$35.53M—2023-03-30From 2021-01-012020-12-31-$12.78M—2022-03-31From 2020-01-012019-12-31-$19.38M—2021-03-31From 2019-01-012018-12-31-$16.87M—2020-03-25From 2018-01-012017-12-31-$14.31M—2019-04-01From 2017-01-012016-12-31-$18.62M—2018-03-20From 2016-01-012015-12-31-$15.56M—2017-03-08From 2015-01-012014-12-31-$15.15M—2016-03-08From 2014-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)